Search Immortality Topics:

Page 21234..1020..»

Category Archives: Pharmacogenomics

Updating the landscape of direct-to-consumer pharmacogenomic testing – Dove Medical Press

Back to Browse Journals Pharmacogenomics and Personalized Medicine Volume 10 Kelly K Filipski,John D Murphy,Kathy J Helzlsouer Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA Abstract: Pharmacogenomics has identified important druggene interactions that affect the safety and efficacy of medications. Continue reading

Posted in Pharmacogenomics | Comments Off on Updating the landscape of direct-to-consumer pharmacogenomic testing – Dove Medical Press

Home [www.esptnet.eu]

(April 14, 2017) Dear ESPT member,First of all, I would like to thank you for your continued support of the European Society for Pharmacogenomics and Personalized Therapy (ESPT). With this email, I would like to update you on the activities of ESPT, and inform you about interactions with you as members regarding the direction and strategies of our society. The ESPT Board has been strengthened in October 2016 by Dr .Sanja Stankovic (Belgrade, Serbia) and Csilla Sipeky (Turku, Finland) Continue reading

Posted in Pharmacogenomics | Comments Off on Home [www.esptnet.eu]

Frost & Sullivan Awards Akonni Biosystems for its Groundbreaking TruDiagnosis Molecular Diagnostics Platform – Markets Insider

Akonni’splatform delivers accurate, multiplexed analysis in a low-cost format, offering a valuable solution for healthcare applications such as disease prediction and prevention, early diagnosis, identification of drug resistance, and treatment monitoring. SANTA CLARA, California, Aug. Continue reading

Posted in Pharmacogenomics | Comments Off on Frost & Sullivan Awards Akonni Biosystems for its Groundbreaking TruDiagnosis Molecular Diagnostics Platform – Markets Insider

Updated Scientific Program | Euro Personalized Medicine …

Sessions and Tracks The 6thEuropeanConference on Predictive Preventive and Personalized Medicine & Molecular Diagnostics will be held on September 14-15, 2017 at Edinburgh, Scotland will be organized around the themeUnleashing the novel approaches in advancing Personalized Medicinewhichcomprises 23 Sessions/Tracksto outline the theme of the conference organized by conferenceseries LLCConferences. The main aim of the conference is to highlight the achievements and innovations in the various fields of Personalized Medicine across the globe. Track 1: Molecular Diagnostics in Personalized Medicine In personalized medicine molecular diagnostics is used for analysing of biological markers and also analysing by applying molecular biology to medical testing .This technique is used to diagnose and monitor disease,detect risk in individual patients .DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule .SNP genotyping is the measurement of genetic variations of single nucleotide polymorphism (SNPs) . Continue reading

Posted in Pharmacogenomics | Comments Off on Updated Scientific Program | Euro Personalized Medicine …

Genes Advice | Pharmacogenomics

Have you or a loved one ever had a bad reaction or unusual side effects when taking a medicine? Reading the long list of allergies, warnings, interactions and other possible complications on any prescription drug leaflet can be scary. Why is it that some drugs work great for some people but dont work well for others? Continue reading

Posted in Pharmacogenomics | Comments Off on Genes Advice | Pharmacogenomics

Global Biomarkers Technologies, Markets and Companies Projections Report 2017 – PR Newswire (press release)

This report describes different types of biomarkers and their discovery using various -omics technologies such as proteomics and metabolomics. Molecular diagnostics technologies are used for the discovery of biomarkers and new tests are also based on biomarker. This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Continue reading

Posted in Pharmacogenomics | Comments Off on Global Biomarkers Technologies, Markets and Companies Projections Report 2017 – PR Newswire (press release)